Navigation Links
DW Healthcare Partners Announces the Sale of Tandem Labs
Date:2/29/2008

SALT LAKE CITY, Feb. 29 /PRNewswire/ -- DW Healthcare Partners (DWHP), a healthcare focused private equity firm, announced today the sale of one of its portfolio companies, NWT Inc. ("Tandem Labs"), to Laboratory Corporation of America(R) Holdings (LabCorp(R)), one of the world's largest clinical laboratory businesses. Headquartered in Salt Lake City, UT, Tandem Labs is a leading bioanalytical and immunoanalytical contract research organization (CRO) supporting pharmaceutical and biotechnology companies with their discovery, preclinical, and clinical drug development programs. The sale of Tandem Labs generated a return for DWHP's investors of approximately 6.9x invested capital. DWHP and Tandem Labs were advised by William Blair & Company during the transaction.

About DW Healthcare Partners

DW Healthcare Partners ("DWHP") is a private equity firm focused exclusively on the healthcare industry. The firm is led by five seasoned healthcare executives with more than 100 years of combined industry experience. DWHP invests in profitable healthcare companies with proven management teams. For more information, please visit http://www.dwhp.com.


'/>"/>
SOURCE DW Healthcare Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... zFlo Motion , a US leader in ... product from a new partner. STT-Systems has developed ... 15 years, with offerings in the optical-motion capture, 3D scanning, ... (inertial measurement unit), iSen, is opening eyes around the world. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Diagenode, ... such as the Bioruptor® and complete solutions for ... for chromatin immunoprecipitation, alleviating the need for manual ... controls needed for ChIP of histones or transcription ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/24/2014)... YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. ... critical areas, announced the closing of an underwritten public offering ... up to an aggregate 3,500,000 shares of common stock, at ... warrant.  The warrants have a per share exercise price of ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... ... ... -- DuPont has entered into agreements to acquire AgVenture, Kentland, Ind.; Hoegemeyer Hybrids, ... business’ PROaccess℠ strategy. Closings are scheduled to occur in the latter part of 2010. ...
... 2 Repligen Corporation (Nasdaq: RGEN ) announced today that it ... on Wednesday, June 9th, 2010 , before the market opens.  The Company ... a conference call and webcast on the same day at 10:00 a.m. ... the Company. , , , ...
... FT. MYERS, Fla., June 2 NeoGenomics, ... will present at the Sixth Annual Noble Financial Equity Conference ... 7, 2010 at the Seminole Hard Rock Hotel in ... Chief Scientific Officer, will give a presentation regarding NeoGenomics, market ...
Cached Biology Technology:DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions 2DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions 3DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions 4Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results 2Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2010 Financial Results 3NeoGenomics to Present at Noble Financial's 6th Annual Equity Conference on Monday, June 7th 2NeoGenomics to Present at Noble Financial's 6th Annual Equity Conference on Monday, June 7th 3
(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, Inc., the ... study that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four hundred years ... as a meeting place for peoples from different continents. This ...
(Date:12/17/2014)... SM announced today its completion of a Good ... current U.S. Food and Drug Administration (FDA) regulations. This ... smart phone application trials utilizing the highest principles for ... determined to improve global healthcare access, quality, and delivery ...
(Date:12/15/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Recognition Market 2015-2019" report to their offering. ... recognition is a technology used for the identification of ... of a person such as nose, jaw edges, mouth, ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... COLUMBIA, Mo. -- Resveratrol, a compound found commonly in ... have several beneficial effects on human health, including cardiovascular ... researcher has discovered that the compound can make prostate ... chances of a full recovery from all types of ...
... nonfood substances, such as earth -- and amylophagy, eating raw ... the U.S. Some 180 species of animals are also known ... A study appearing Oct. 17 in the online journal ... of pica in Madagascar. It is one of only a ...
... Society of Environmental Toxicology and Chemistry will present the SETAC/ICA ... Annual Meeting, November 11 at the Long Beach Convention and ... School of Marine & Atmospheric Science of the University of ... understanding of fate and effects of metals in the environment, ...
Cached Biology News:Compound in grapes, red wine could be key to fighting prostate cancer 2Study documents eating of soil, raw starch in Madagascar 2SETAC announces Chris Lee Award for metals research winner, Kevin Brix 2
Phospho-TAK1 (Thr184/187) (90C7) Rabbit mAb Shipping Temperature: Cold Storage Temperature: -20C...
Gamma delta T Lymphocytes Purified Anti-Porcine clone MAC320, Isotype Rat IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
... (Ser843) Immunogen: ... encompassing the human, mouse, and rat ... Number: NM_153831 ... by immunoblot. ...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
Biology Products: